Norwegian Adult Mental Health Registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

• Ages 18 years and older
• All sexes
• No healthy volunteers
• Adult, Older adult

Study population: Residents in Norway aged 18 years or older and granted right to treatment in mental specialized in- and out-patient settings (approximately 150.000 participants)

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Conditions

Depression, Schizophrenia, Bipolar Disorder, Eating Disorders, Anxiety Disorders, Ptsd

Keywords

database, epidemiology, mental health register

Medical subject headings

Depression, Schizophrenia, Bipolar Disorder, Feeding and Eating Disorders, Anxiety Disorders, Stress Disorders, Post-Traumatic, Personality Disorders, Attention Deficit Disorder with Hyperactivity

What is being measured

The primary outcome is the main question the study is designed to answer.

1. Patient Reported Outcome Measures (PROMs)

   Percentage of subjects that experienced change in PROMs

   Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

2. Patient Reported Outcome Measures (PROMs)

   Percentage of subjects that experienced change in PROMs

   Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

3. Patient Reported Outcome Measures (PROMs)

   Percentage of subjects that experienced change in PROMs

   Measured: Six months after discharge

4. Drug name and dosage from electronic medication management solutions

   Frequency of psychotropic generic drug name and dosage

   Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

5. Drug name and dosage from electronic medication management solutions

   Frequency of psychotropic generic drug name and dosage

   Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

6. Drug name and dosage from electronic medication management solutions

   Frequency of psychotropic generic drug name and dosage

   Measured: Six months after discharge from any cause, assessed up to 12 months

7. Rate of overweight defined as BMI > 25 (body mass index)

   Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters.

   Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

8. Rate of overweight defined as BMI > 25 (body mass index)

   Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters.

   Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

9. Level of glycated haemoglobin (HbA1c)

   Glycated hemoglobin is a form of hemoglobin chemically linked to sugar.

   Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

10. Level of glycated haemoglobin (HbA1c)

    Glycated hemoglobin is a form of hemoglobin chemically linked to sugar.

    Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

11. Level of blood pressure, both systolic and diastolic levels

    Blood pressure varies between systolic and diastolic pressures after each heartbeat. Systolic pressure is peak (maximum) pressure in the arteries. Diastolic pressure is the lowest (minimum) pressure in the arteries.

    Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

12. Level of blood pressure, both systolic and diastolic levels

    Blood pressure varies between systolic and diastolic pressures after each heartbeat. Systolic pressure is peak (maximum) pressure in the arteries. Diastolic pressure is the lowest (minimum) pressure in the arteries.

    Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

13. Bloodlevels of total cholesterol, LDL, HDL and Triglycerides

    A lipid profile (lipid panel) is a set blood tests used to find abnormalities in blood lipids. The present panel will include: total cholesterol, LDL, HDL and Triglycerides.

    Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

14. Bloodlevels of total cholesterol, LDL, HDL and Triglycerides

    A lipid profile (lipid panel) is a set blood tests used to find abnormalities in blood lipids. The present panel will include: total cholesterol, LDL, HDL and Triglycerides.

    Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

15. Frequency of ICD-10 or ICD-11 diagnosis F00-F99

    International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) or ISD-11: Chapter V: Mental and behavioural disorders (F00-F99)

    Measured: Baseline defined as: From start of treatment date (inclusion in the register) until the date of first documented assessment or date of discharge from any cause, whichever came first, assessed up to 24 months

16. Frequency of ICD-10 or ICD-11 diagnosis F00-F99

    International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) or ISD-11: Chapter V: Mental and behavioural disorders (F00-F99)Revision (ICD-10) WHO: Chapter V: Mental and behavioural disorders (F00-F99)

    Measured: Discharge defined as: date of discharge from any cause, assessed up to 60 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

1. First posted2 Nov 2023
2. Study start1 Jan 2024 (estimated)
3. Primary completion31 Dec 2030 (estimated)
4. Study completion31 Dec 2030 (estimated)

Resources

• Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
• Publications (1)Papers the sponsor has linked to this study.
• Other trials for DepressionStudies of the same condition, open and under way.
• What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.